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Left ventricular systolic function deterioration during dobutamine
stress echocardiography as an early manifestation of diabetic cardio-
myopathy and reversal by optimized therapeutic approach
Falah Aboukhoudir, Sofiene Rekik [Orateur]
CH Avignon, Avignon, France
Introduction: Diabetes mellitus has been associated with changes in the
structure and function of the myocardium manifesting in the early stages of
the disease as subtle systolic and diastolic dysfunction; the role of dobutamine
stress echocardiography (DSE) in this setting remains unclear.
Aims: We sought to evaluate the prevalence of dobutamine-induced sys-
tolic dysfunction amongst diabetic patients with normal at rest left ventricular
ejection fraction and no coronary artery disease and to investigate whether an
optimized therapeutic approach can reverse these abnormalities.
Methods: 1363 patients with DM referred to our echocardiography labora-
tory for DSE between January 2008 and June 2010 were prospectively inves-
tigated. Patients with normal left ventricular ejection fraction (LVEF) at rest
and significant deterioration during peak dobutamine infusion (defined as a
10% decrease) in the absence of coronary artery disease or vasospasm were
enrolled. They received on top of their usual treatment 5 mg perindopril and
had their glycemic control intensified. At 60 days, all of them were controlled
for clinical status and underwent a control DSE.
Results: 18 patients were included, there were 9 males and 9 females,
mean age was 66.1±10.2 years. All the patients had type II DM with a
mean duration of 12.7±6.6 years. They all had normal at rest echocardio-
graphic findings with no wall motion abnormalities; mean LVEF was
62±6%. At peak dobutamine, LVEF significantly deteriorated in all the
patients with a mean 15±5% decrease compared to baseline. After therapeutic
optimization, Glycated haemoglobin improved from 8.53±2.05% to 6.8±0.6%
(HbA1C=1.73%, p=0.001), mean LVEF at peak dobutamine infusion
evolved from 47.17±4.2% pre-optimization to 58±4.8% at control (10.83%
improvement; p <0.001).
Conclusion: In patients with DM and normal at rest LVEF, Dobutamine
infusion during DSE can induce a significant deterioration in LVEF in the
absence of coronary artery disease or vasospasm. This specific condition could
be largely reversed through an optimized therapybased on a tighter metabolic
control and a more stringent renin-angiotensin-aldosterone system inhibition.
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Left ventricular contractile reserve in asymptomatic degenerative
mitral regurgitation: evaluation and impact on outcome
Julien Magne [Orateur] (1), Kim O’Connor (1), Haifa Mahjoub (2), Philippe
Pibarot (2), Luc A. Piérard (1), Patrizio Lancellotti (1)
(1) CHU Sart Tilman, Cardiologie, Liège, Belgique – (2) Centre de
Recherche de l’Hôpital Laval, Québec, Canada
Introduction: In degenerative mitral regurgitation (MR), the evaluation of
left ventricular contractile reserve (LVCR) remains understudied. The LVCR
is evaluated either with the exercise (ex) – induced changes in LV ejection
fraction (LVEF) or in global longitudinal strain (GLS), as assessed by 2-D
speckle-tracking imaging (2DSt). We sought to quantify LVCR and evaluate
its usefulness for risk stratification in asymptomatic patient with degenerative
MR.
Method and results: Comprehensive resting and exercise transthoracic
echocardiography, including 2DSt quantification were performed in
112 consecutive asymptomatic patients (with moderate to severe degener-
ative MR and preserved LV function. Presence of LVCR was defined as
an ex-induced increase in LVEF (LVCREF) >4% or in GLS (LVCRGLS)
>2%. LVCREF was present in 39 (45%) and LVCRGLS in 59 (51%). BNP
level was significantly correlated with ex-induced changes in GLS (r=–
0.20, p=0.025), but not in LVEF (r=0.03, p=0.22) and patients with
LVCRGLS had lower BNP level (39±44 vs. 73±79pg/ml, p=0.005). Patients
with no LVCRGLS had significant lower 2-year cardiac event-free survival
(48±7 vs. 70±7%, p=0.003). In contrast, there was no significant differ-
ence in outcome regarding to the presence or absence of LVCREF (58±8
vs. 63±8%, p=0.20). Multivariable Cox proportional hazard model showed
that no LVCRGLS remained associated with lower event-free survival after
adjustment for age and sex (HR=2.3, 95%CI: 1.2-4.3, p=0.008). LVCREF
was not associated with an increase in risk of events both in uni- and
multivariable analysis.
Conclusion: In asymptomatic degenerative MR, LVCR
 
should be assessed
using ex-induced changes in LV myocardial longitudinal function rather than
changes in LVEF. In patients with preserved resting LV function, the absence
of LVCR on exercise is independently associated with 2-fold increase in risk
of cardiac events. Hence, LVCR may be useful to improve risk stratification
and clinical decision making in asymptomatic patients with degenerative MR.
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LV dyssynchrony is superior to peak strain for differentiating physiologic
from pathologic left ventricular hypertrophy: a 2D and 3D speckle
tracking analysis
Camille Brémont [Orateur], Alexandre Bensaid, Henrique Alonso, Olfa
Zaghden, Anne-Sophie Olezac, Julien Nahum, Jean-Luc Dubois-Randé,
Pascal Guéret, Pascal Lim
AP-HP, CHU Henri Mondor, Cardiologie, Créteil, France
Aims: Differentiation between physiologic and pathologic left ventricular
(LV) hypertrophy may be challenging in athlete with moderate LV septal
hypertrophy (13mm to 15mm). We hypothesized that this issue may be over-
come by myocardial deformation indexes derived from 2D and 3D strain by
speckle tracking.
Methods: Comprehensive 2D and 3D echocardiography was prospectively
performed in 103 subjects: 49 with hypertrophic cardiomyopathies preserved
LVEF>50% (HCM, 57±14 years, EF=61±6%); 34 professional athletes
(27±5 years, EF=58±4%) and 20 control subjects (39±12 years, EF=62±4%).
Peak global strain was computed from 2D (longitudinal) and 3D speckle
tracking (longitudinal, radial, circumferential, and area) and LV dyssynchrony
defined as the standard deviation of time to peak longitudinal strain (12SD)
was derived from 2D speckle tracking.
Results: Septal thickness averaged 19±5 mm in HCM (>15 mm
[n=40], between 13 and 15 mm [n=9]), 12±2 mm in athletes (between 13
and 15 mm [n=15], <13 mm [n=19]) and 10±1.5 mm in controls
(p<0.0001 for all). Overall, 2D and 3D peak strain was lower in HCM than
in control and athlete subjects. In patients with moderate septal thickness
(13-15 mm), only 2D and 3D longitudinal global peak strain (–18±2% vs.
–15±3%, p=0.03) and longitudinal myocardial dyssynchrony by 2D
(70±31 ms vs. 40±10 ms, p=0.004) differed between HCM and athletes.
However, LV dyssynchrony (AUC=0.87 for 12SD) appeared superior to
peak strain (AUC=0.75 for 2D and AUC=0.79 for 3D) to identify mod-
erate abnormal LV hypertrophy (13-15 mm). Sensitivity and specificity to
identify moderate abnormal LV hypertrophy was 89% and 73%, respec-
tively when LV dyssynchrony >45 ms.
Conclusion: LV longitudinal dyssynchrony accurately differentiates
physiologic LV hypertrophy (13-15mm) in athlete from abnormal LV hyper-
trophy in HCM.
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